OpenAI’s quiet step toward Wall Street has escalated the AI race from research labs to public markets, pitting financial timelines against long-term visions for artificial intelligence.

On June 8, OpenAI revealed it had “recently submitted a confidential S-1” to the U.S. Securities and Exchange Commission, saying it expected the move to leak and was “just announcing it.”¹ The company stressed it has “not decided on timing yet; it may be a while because there are things we want to do that are likely easier as a private company,” framing the filing as a way to preserve “the option to go public sooner if that ends up being best.”¹

Human-focused outlets quickly framed the filing as the first formal step toward a blockbuster IPO. Business Insider described it as OpenAI’s “confidential S-1, the first official step toward a blockbuster IPO,” while underscoring the company’s caveat that “it may be a while” before shares actually list.² Axios similarly reported that the filing “gives it the option to tap public markets,” even as OpenAI insists its focus remains on building AI products.³

The timing sharpened the rivalry with Anthropic. TechCrunch noted that OpenAI’s move came “a little more than a week after its main rival, Anthropic, also filed to go public,” intensifying a race between the two labs that are both expected to seek valuations near or above $1 trillion.⁴ The Verge called OpenAI’s prospective listing “one of the most highly anticipated public offerings in history” and highlighted that Anthropic’s most recent funding round put its valuation ahead of OpenAI’s.⁵

Analysts see the dual IPOs as a stress test for investor appetite. AI Magazine argued that OpenAI and Anthropic’s offerings will “introduce pure-play Gen AI giants to public markets for the first time,” gauging Wall Street’s readiness to underwrite the sector.⁶ A Business Insider roundup quoted Wedbush analyst Dan Ives saying OpenAI’s filing shows “the floodgates for the IPO market are officially open,” as both labs “race to get to market as quickly as possible to beat one another out” for capital.⁷

Yet the shift toward public markets also surfaces deeper tensions. A tweet amplified by AI researcher Yann LeCun warned of a “collision course between those who believe research and science should be open and those who believe we are in an accelerating singularity curve,” capturing anxieties that IPO-driven incentives could clash with open, public-interest AI research.Yann LeCun (ylecun)⁸

---